Proactive Investors - Run By Investors For Investors

Neurotrope anticipates data from its drug to treat Alzheimer's summer 2019

Neurotrope Inc (NASDAQ:NTRP) CEO Dr. Charles Ryan sat down with Proactive Investors at the BIO CEO & Investor Conference in New York.

Ryan says the company anticipates data from its drug to treat Alzheimer's summer 2019.

 
View full NTRP profile View Profile

Neurotrope Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use